Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00398177 · ClinicalTrials.gov registry record
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
A clinical trial of Lymphoma, Non-Hodgkin and Hodgkin's Disease, sponsored by Stanford University.
- Recruiting
- Registry status
- 1
- Study location
NCT00398177: Recruiting study of Lymphoma, Non-Hodgkin and Hodgkin's Disease, sponsored by Stanford University.
NCT00398177 is a study of Lymphoma, Non-Hodgkin and Hodgkin's Disease that is actively recruiting participants, run by Stanford University. The registry lists this as an open-ended (no fixed target) study. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00398177, a study of Lymphoma, Non-Hodgkin and Hodgkin's Disease, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- open-ended (no fixed target)
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
Conditions Studied
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | open-ended (no fixed target) |
| Start Date | 1999-01 |
| Est. Completion | 2099-01 |
What NCT00398177 shows while recruiting
NCT00398177 is an observational study that tracks outcomes without assigning an intervention. The registry lists this as an open-ended (no fixed target) study, common for long-running registries that collect data indefinitely.
The record links to 2 conditions, with Lymphoma, Non-Hodgkin appearing as the primary indexed condition, and to 0 interventions.
NCT00398177 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00398177 about?
NCT00398177 is a clinical study titled "Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease". The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
What is the current status of trial NCT00398177?
This trial is currently recruiting. The enrollment target is open-ended (no fixed target). The study started on 1999-01. Estimated completion is 2099-01.
What conditions does trial NCT00398177 study?
This clinical trial studies the following conditions: Lymphoma, Non-Hodgkin, Hodgkin's Disease.
Who is sponsoring clinical trial NCT00398177?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00398177 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma, Non-Hodgkin
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
RECRUITING · Phase 1
-
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
RECRUITING · Phase 1
-
Family Study of Lymphoproliferative Disorders
RECRUITING
-
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
RECRUITING · Phase 1
-
Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma
RECRUITING · Phase 1
-
Epcoritamab-CAR T Cells for Large B-cell Lymphomas
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia